Skip to content

    MYRIAD GENETICS (MYGN) stock price & financials

    View MYGN earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance46.7% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $213.30M
    $210.60M
    $195.90M
    $213.10M
    $205.70M
    -3.6%
    $209.80M
    -0.4%
    $200.40M
    +2.3%
    $190.70M
    -10.5%
    Stable
    Operating Profit
    -$20.00M
    -$39.10M
    -$29.00M
    -$329.20M
    -$23.30M
    -16.5%
    -$5.70M
    +85.4%
    -$30.70M
    -5.9%
    -$38.90M
    +88.2%
    Strengthening
    Net Profit
    -$22.10M
    -$42.50M
    -$100.0K
    -$330.50M
    -$27.40M
    -24.0%
    -$7.90M
    +81.4%
    -$34.10M
    -34000.0%
    -$43.20M
    +86.9%
    Weakening
    EPS
    $-0.24
    $0.00
    $-3.57
    $-0.29
    -20.8%
    $-0.36
    $-0.46
    +87.1%
    Strengthening
    Other Income
    -$1.20M
    -$100.0K
    -$400.0K
    -$1.40M
    -$2.90M
    -141.7%
    -$3.20M
    -3100.0%
    -$3.40M
    -750.0%
    -$3.70M
    -164.3%
    Weakening
    Interest
    $800.0K
    $700.0K
    $800.0K
    $1.50M
    $3.80M
    +375.0%
    $4.40M
    +528.6%
    $4.10M
    +412.5%
    $4.10M
    +173.3%
    Strengthening
    Depreciation
    Profit before Tax
    -$21.20M
    -$39.20M
    -$29.40M
    -$330.60M
    -$26.20M
    -23.6%
    -$8.90M
    +77.3%
    -$34.10M
    -16.0%
    -$42.60M
    +87.1%
    Strengthening
    MarginsOPM
    -9.4%
    -18.6%
    -14.8%
    -154.5%
    -11.3%
    -20.8%
    -2.7%
    +85.4%
    -15.3%
    -3.5%
    -20.4%
    +86.8%
    Strengthening
    Tax
    -4.3%
    -8.4%
    99.7%
    0.0%
    -4.6%
    -7.8%
    11.2%
    0.0%
    -100.0%
    -1.4%
    -4800.0%
    Weakening
    ReturnsROIC
    1.8%
    3.5%
    0.0%
    27.6%
    2.3%
    +24.0%
    0.7%
    -81.4%
    2.8%
    +34000.0%
    3.6%
    -86.9%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY19FY20FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$93.20M$163.70M$117.00M$257.40M$56.90M$132.10M$102.40M$149.60M$115.20M
    Short-Term Investments$43.70M$54.10M$33.70M$81.40M$58.00M$8.80M$0
    Total Current Assets$348.60M$331.70M$389.40M$484.80M$274.60M$313.60M$298.00M$332.60M$289.00M
    Net PP&E$57.30M$103.00M$100.40M$125.30M$187.30M$180.60M$172.40M$163.40M$158.90M
    Goodwill$417.20M$327.60M$329.20M$239.20M$286.80M$287.40M$286.30M$51.60M$47.10M
    Intangibles$684.70M$605.30M$576.50M$404.10M$379.70M$349.50M$262.40M$153.40M$139.00M
    Total Assets$1.56B$1.40B$1.42B$1.32B$1.20B$1.15B$1.03B$706.60M$638.90M
    LiabilitiesTotal Current Liabilities$117.80M$147.00M$145.90M$204.30M$137.20M$155.90M$164.10M$133.80M$130.70M
    Short-Term Debt$0$0
    Long-Term Debt$233.50M$224.40M$224.80M$0$0$38.50M$39.60M$119.90M$120.70M
    Long-Term Leases$0$56.90M$50.60M$79.30M$130.90M$97.40M$87.90M$83.00M$82.50M
    Total Liabilities$473.80M$486.40M$537.80M$352.90M$312.90M$363.30M$326.50M$338.60M$335.00M
    EquityCommon Stock & APIC$700.0K$700.0K$800.0K$800.0K$800.0K$900.0K$900.0K$900.0K$1.00M
    Retained Earnings$25.60M-$173.90M-$227.00M-$254.20M-$366.20M-$629.50M-$756.80M-$1.12B-$1.20B
    Total Equity$1.09B$918.20M$881.00M$967.80M$885.80M$783.20M$701.10M$368.00M$303.90M
    HighlightsNet Cash / (Debt)-$74.10M$62.80M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$115.90M$83.70M$60.70M$18.60M-$106.30M-$110.90M-$8.70M$1.80M$7.70M
    Cash from Investing-$11.60M-$286.40M$19.30M$274.40M-$77.50M$31.90M-$11.90M-$27.40M-$21.90M
    Cash from Financing-$95.00M$182.30M-$10.00M-$150.60M-$8.00M$152.90M-$7.40M$64.20M$47.20M
    SummaryCapital Expenditure-$8.40M-$8.60M-$10.20M-$18.00M-$45.30M
    Free Cash Flow$107.50M$75.10M$50.50M$600.0K-$151.60M
    FCF Margin14.5%8.8%7.9%0.1%-22.3%

    Ratios